- About Us
- Reproductive Health & Pregnancy Therapeutics
- Our Pipeline
- News & Events
At ObsEva, our passion and expertise in reproductive health and pregnancy therapeutics is helping millions of women worldwide lead healthier and more fulfilling lives.
Millions of women worldwide suffer from reproductive health conditions that affect their quality of life or ability to conceive and may lead to complications during pregnancy.
ObsEva is advancing a robust pipeline of novel, orally-administered, clinical-stage compounds in the areas of uterine fibroids, endometriosis, assisted reproductive technology, and preterm labor.
ObsEva Expands Leadership Team and Board of Directors with Industry VeteransRead More
ObsEva Announces Completion of Phase 1 First-in-Women Study of OBE022 for the Treatment of Preterm LaborRead More
ObsEva Announces Results of the IMPLANT Phase 2 Trial of OBE001 (nolasiban) for the Improvement of Pregnancy and Live Birth Rates Following IVF/ICSIRead More
ObsEva Announces Plans to Conduct Initial Public Offering in the United StatesRead More